Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

Similar articles for PubMed (Select 15056761)

1.

Induction of oral tolerance to prevent diabetes with transgenic plants requires glutamic acid decarboxylase (GAD) and IL-4.

Ma S, Huang Y, Yin Z, Menassa R, Brandle JE, Jevnikar AM.

Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5680-5. Epub 2004 Mar 31.

2.

Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance.

Ma SW, Zhao DL, Yin ZQ, Mukherjee R, Singh B, Qin HY, Stiller CR, Jevnikar AM.

Nat Med. 1997 Jul;3(7):793-6.

PMID:
9212110
3.
4.

Improved in planta expression of the human islet autoantigen glutamic acid decarboxylase (GAD65).

Avesani L, Falorni A, Tornielli GB, Marusic C, Porceddu A, Polverari A, Faleri C, Calcinaro F, Pezzotti M.

Transgenic Res. 2003 Apr;12(2):203-12.

PMID:
12739888
5.

Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase.

Jun HS, Chung YH, Han J, Kim A, Yoo SS, Sherwin RS, Yoon JW.

Diabetologia. 2002 May;45(5):668-76. Epub 2002 Apr 4.

PMID:
12107747
6.

Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism.

Gong Z, Pan L, Le Y, Liu Q, Zhou M, Xing W, Zhuo R, Wang S, Guo J.

Vaccine. 2010 May 28;28(24):4052-8. doi: 10.1016/j.vaccine.2010.04.005. Epub 2010 Apr 18.

PMID:
20406664
7.

A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice.

Tisch R, Wang B, Atkinson MA, Serreze DV, Friedline R.

J Immunol. 2001 Jun 1;166(11):6925-36.

8.

Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.

Qin HY, Elliott JF, Lakey JR, Rajotte RV, Singh B.

J Autoimmun. 1998 Dec;11(6):591-601.

PMID:
9878081
10.

Protection of NOD mice from type 1 diabetes after oral inoculation with vaccinia viruses expressing adjuvanted islet autoantigens.

Denes B, Krausova V, Fodor N, Timiryasova T, Henderson D, Hough J, Yu J, Fodor I, Langridge WH.

J Immunother. 2005 Sep-Oct;28(5):438-48.

PMID:
16113600
11.

Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice.

Elliott JF, Qin HY, Bhatti S, Smith DK, Singh RK, Dillon T, Lauzon J, Singh B.

Diabetes. 1994 Dec;43(12):1494-9.

PMID:
7525393
12.

Cloning, expression, purification and characterization of the cholera toxin B subunit and triple glutamic acid decarboxylase epitopes fusion protein in Escherichia coli.

Gong Z, Long X, Pan L, Le Y, Liu Q, Wang S, Guo J, Xiao B, Zhou M, Mei D.

Protein Expr Purif. 2009 Aug;66(2):191-7. doi: 10.1016/j.pep.2009.04.002. Epub 2009 Apr 11.

PMID:
19364533
13.

Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.

Kim SK, Tarbell KV, Sanna M, Vadeboncoeur M, Warganich T, Lee M, Davis M, McDevitt HO.

Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14204-9. Epub 2004 Sep 20.

14.

Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells.

Ploix C, Bergerot I, Durand A, Czerkinsky C, Holmgren J, Thivolet C.

Diabetes. 1999 Nov;48(11):2150-6.

PMID:
10535448
15.

Endogenous expression levels of autoantigens influence success or failure of DNA immunizations to prevent type 1 diabetes: addition of IL-4 increases safety.

Wolfe T, Bot A, Hughes A, Möhrle U, Rodrigo E, Jaume JC, Baekkeskov S, von Herrath M.

Eur J Immunol. 2002 Jan;32(1):113-21.

PMID:
11754351
16.

Widespread expression of an autoantigen-GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease.

Geng L, Solimena M, Flavell RA, Sherwin RS, Hayday AC.

Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10055-60.

17.

Effect of oral and intravenous insulin and glutamic acid decarboxylase in NOD mice.

Ramiya VK, Shang XZ, Wasserfall CH, Maclaren NK.

Autoimmunity. 1997;26(3):139-51.

PMID:
9550282
18.

Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes.

Tian J, Atkinson MA, Clare-Salzler M, Herschenfeld A, Forsthuber T, Lehmann PV, Kaufman DL.

J Exp Med. 1996 Apr 1;183(4):1561-7.

19.

Autoantigens produced in plants for oral tolerance therapy of autoimmune diseases.

Ma S, Jevnikar AM.

Adv Exp Med Biol. 1999;464:179-94. Review.

PMID:
10335394
20.

Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase.

Jaeckel E, Klein L, Martin-Orozco N, von Boehmer H.

J Exp Med. 2003 Jun 16;197(12):1635-44. Epub 2003 Jun 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk